Capivasertib-induced polymorphous lichenoid exanthem: Report of a novel AKT kinase inhibitor-related drug eruption
Saved in:
| Main Authors: | Raj P. Fadadu, MD, MS, Albert Lee, BA, Brian Hinds, MD, Charisse Orme, MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512625002383 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delayed lichenoid drug eruption associated with apremilast
by: Betty Hinderks-Davis, MD, et al.
Published: (2025-05-01) -
Methotrexate-induced epidermal necrosis following intrathecal chemotherapy: A case report
by: Brad R. Woodie, BS, et al.
Published: (2025-02-01) -
Immune checkpoint inhibitor associated lichenoid dermatitis mimicking erythema multiforme major with a germline variant in human leukocyte antigen-B15
by: Sach Thakker, BS, et al.
Published: (2025-02-01) -
Successful Treatment of Ustekinumab-Associated Lichenoid Drug Eruption with Upadacitinib: A Case Report
by: Xia M, et al.
Published: (2025-04-01) -
Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia
by: Avery Watson, M4, et al.
Published: (2025-07-01)